查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1453906

到 2030 年芽孢桿菌凝固剂市场预测：按产品类型、型态、分销管道、应用、最终用户和地区进行的全球分析

Bacillus Coagulans Market Forecasts to 2030 - Global Analysis By Product Type (Animal-Based and Plant-Based), Form (Spore, Liquid and Powder), Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年凝结芽孢桿菌的全球市场规模为 1.03 亿美元，预计在预测期内将以 10.1% 的复合年增长率增长，并在 2030 年达到 2.02 亿美元。

凝结芽孢桿菌是一种有益细菌，通常用作益生菌，因为它能够促进消化器官系统健康和支持免疫功能。它是一种形成孢子、产生乳酸的细菌，可以承受高温、酸度和胆盐等恶劣条件，使其具有高度的弹性和有效的营养补充。形成孢子的乳酸菌可透过抑制有害细菌的生长并促进有益细菌的生长，有助于维持肠道菌丛的健康平衡。

扩大益生菌

益生菌因其潜在的健康益处而受到广泛关注，特别是支持消化器官系统健康和免疫功能。作为一种益生菌，凝结芽孢桿菌正受益于此不断增长的市场趋势。此外，医疗保健专业人员和研究人员透过科学研究和临床试验积极宣传包括凝结芽孢桿菌在内的益生菌的益处。这些研究的正面结果有助于增强人们对益生菌作为可行健康解决方案的信任和接受，进一步支持市场扩张。

产品稳定性

凝结芽孢桿菌是一种活菌，对温度、湿度和氧气暴露等各种环境因素敏感。然而，凝结芽孢桿菌可能对最佳生长和存活有特定的要求，例如 pH 值、营养可用性以及与其他成分的相容性。在产品的整个保质期内保持凝结芽孢桿菌的稳定性和活力是很困难的，产品的不稳定性会影响其有效性和消费者信心，从而抑制市场需求。

消费者意识不断增强

随着消费者越来越意识到自己的健康和福祉，对支持消化器官系统健康的天然有效解决方案的需求不断增加。孢子形成乳酸菌因其特性而作为潜在的治疗剂而引起人们的关注，从而导致消费者意识和需求的增加。此外，健康和保健出版物、线上资源、社交媒体和口碑推荐都在教育消费者了解凝结芽孢桿菌的益处方面发挥作用。

替代产品的竞争

乳酸桿菌和双歧桿菌等替代益生菌菌株具有类似的健康益处，并且在市场上已确立地位，形成了竞争格局。此外，益生元、合益素和传统药物等非益生菌替代品也正在争取类似健康状况和健康目标的市场占有率。既定竞争对手和替代产品的存在强调了芽孢桿菌凝固剂产品差异化和价值提案的重要性，并影响市场需求。

COVID-19 的影响

全球凝结芽孢桿菌市场受到 COVID-19 大流行的严重影响。这场大流行导致人们重新评估健康优先事项，导致对含有凝结芽孢桿菌的机能性食品和益生菌的需求增加。此外，疫情也造成供应链中断，影响了各地区机能性食品的商业性生产。

预计粉末细分市场在预测期内将是最大的

由于其多功能性、便利性和易于融入各种应用，粉末产业预计将占据最大的市场份额。凝结芽孢桿菌粉是益生菌的浓缩型态，常用于营养补充、机能性食品和饲料添加剂。此外，凝结芽孢桿菌粉末补充品为消费者提供了一种将益生菌融入日常生活的便捷方式。该粉末可以混合到食品和饮料、优格中，或撒在食品上，提供一种简单且可客製化的方法来促进肠道健康和免疫力。

预计非乳製品产业在预测期内复合年增长率最高

由于对无乳製品、纯素友善和益生菌产品的需求不断增加，预计非乳製品市场在预测期内将出现良好成长。由于凝结芽孢桿菌是一种有弹性的孢子形成细菌，因此适合添加到非乳製品食品和食品和饮料中，为消费者提供获得益生菌相关健康益处的另一种选择。此外，清洁标籤和天然成分的成长趋势将进一步推动对非乳製品益生菌选择的需求，因为凝结芽孢桿菌通常被认为是一种天然且清洁标籤友善的成分。

占比最大的地区：

在估计期间，北美占据了最大的市场占有率。随着消费者越来越意识到消化器官系统健康的重要性，对含有凝结芽孢桿菌的产品的需求正在增加。这种需求是由忙碌的生活方式、不良的饮食习惯和胃肠道疾病增加等因素所推动的。此外，北美，特别是美国和加拿大的法规环境支持在食品和营养补充中使用凝结芽孢桿菌，进一步推动市场成长。

复合年增长率最高的地区：

由于亚太地区人口众多且多样化、可支配收入不断增加以及健康意识不断增强，预计亚太地区在预测期内将出现盈利成长。凝结芽孢桿菌具有承受高温和酸性环境的能力，使其适合发酵过程，使其成为增加泡菜、味噌、Tempeh和泡菜等传统亚洲食品的营养价值和益生菌含量的流行选择。此外，胃肠道疾病和消化器官系统健康问题在该地区普遍存在，导致人们越来越认识到肠道健康和益生菌的重要性。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球芽孢桿菌凝固市场：依产品类型

  • 动物起源
  • 植物来源

第六章全球芽孢桿菌凝固市场：型态

  • 孢子
  • 液体
  • 粉末

第七章全球芽孢桿菌凝固市场：依通路

  • 线下零售
  • 网路零售

第八章全球芽孢桿菌凝固市场：依应用分类

  • 粮食
  • 婴儿营养
  • 非乳製品
  • 益生菌补充品
  • 其他用途

第九章全球芽孢桿菌凝固市场：依最终用户分类

  • 饮食
  • 化妆品
  • 营养补充食品
  • 药品
  • 家畜
  • 其他最终用户

第十章全球芽孢桿菌凝固市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Mitsubishi Chemical Foods Corporation
  • Aumgene Bioscience
  • Nebraska Cultures
  • Syngen Biotech
  • Sabinsa Corporation
  • UAS Laboratories
  • Ganeden
  • Microbax
  • Mystical Biotech Pvt. Ltd
  • Sanzyme
  • Synbiotics Limited
  • Lallemand Inc.
  • Bioriginal Food & Science Corp.
  • Unique Biotech Limited
  • Biovation Labs Inc.
Product Code: SMRC25458

According to Stratistics MRC, the Global Bacillus Coagulans Market is accounted for $103 million in 2023 and is expected to reach $202 million by 2030 growing at a CAGR of 10.1% during the forecast period. Bacillus coagulans is a beneficial bacterium commonly used as a probiotic due to its ability to promote digestive health and support immune function. It is a spore-forming, lactic acid-producing bacterium that can survive harsh conditions such as heat, acidity, and bile salts, making it highly resilient and effective as a dietary supplement. Bacillus coagulans aids in maintaining a healthy balance of gut flora by inhibiting the growth of harmful bacteria and promoting the growth of beneficial bacteria.

Market Dynamics:

Driver:

Expansion of the probiotics

Probiotics have gained considerable attention due to their potential health benefits, particularly in supporting digestive health and immune function. As a probiotic bacterium, Bacillus coagulans has benefited from this growing market trend. Furthermore, healthcare professionals and researchers have been actively promoting the benefits of probiotics, including Bacillus coagulans, through scientific studies and clinical trials. Positive findings from these studies have contributed to the credibility and acceptance of probiotics as a viable health solution, further propelling market expansion.

Restraint:

Product stability

Bacillus coagulans is a live bacterium that is sensitive to various environmental factors, including temperature, moisture, and oxygen exposure. However, Bacillus coagulans may have specific requirements for optimal growth and survival, including pH levels, nutrient availability, and compatibility with other ingredients. Maintaining the stability and viability of Bacillus coagulans throughout the product's shelf life can be challenging, and product instability can affect its effectiveness and consumer trust, which hampers the market demand.

Opportunity:

Increasing consumer awareness

As consumers become more conscious of their health and well-being, there is a growing demand for natural and effective solutions to support digestive health. Bacillus coagulans, with its properties, has gained attention as a potential remedy, leading to increased consumer awareness and demand. Furthermore, health and wellness publications, online resources, social media, and word-of-mouth recommendations have all played a role in educating consumers about the benefits of Bacillus coagulans.

Threat:

Competition from alternative products

Alternative probiotic strains, such as Lactobacillus and Bifidobacterium species, offer similar health benefits and are well-established in the market, creating a competitive landscape. Additionally, non-probiotic alternatives, such as prebiotics, synbiotics, and conventional pharmaceuticals, compete for market share by targeting similar health conditions or wellness goals. The presence of established competitors and alternative products underscores the importance of differentiation and value proposition for Bacillus coagulans products, which impact the market demand.

Covid-19 Impact

The global Bacillus Coagulans market has experienced significant impacts due to the COVID-19 pandemic. The pandemic has led to a revaluation of health priorities, resulting in an increased demand for functional foods and probiotics, including Bacillus Coagulans. Moreover, the pandemic has caused disruptions in the supply chain, impacting the commercial manufacturing of functional food products in various regions.

The powder segment is expected to be the largest during the forecast period

The powder segment is estimated to hold the largest share, due to their versatility, convenience, and ease of incorporation into various applications. Bacillus coagulans powder is a concentrated form of the probiotic bacterium, often used in dietary supplements, functional foods, and animal feed additives. Moreover, powdered Bacillus coagulans supplements offer consumers a convenient way to incorporate probiotics into their daily routines. The powder can be easily mixed into beverages, yogurt, or sprinkled over food, providing a simple and customizable way to boost gut health and immunity.

The non-dairy segment is expected to have the highest CAGR during the forecast period

The non-dairy segment is anticipated to have lucrative growth during the forecast period, due to the increasing demand for dairy-free and vegan-friendly probiotic products. Bacillus coagulans, being a resilient spore-forming bacterium, is well-suited for incorporation into non-dairy foods and beverages, offering consumers alternative options for obtaining the health benefits associated with probiotics. Moreover, the growing trend towards clean label and natural ingredients has further fuelled the demand for non-dairy probiotic options, as Bacillus coagulans is often perceived as a natural and clean-label-friendly ingredient.

Region with largest share:

North America commanded the largest market share during the extrapolated period. With increasing awareness among consumers about the importance of digestive health and wellness, there has been a growing demand for products containing Bacillus coagulans. This demand is driven by factors such as hectic lifestyles, poor dietary habits, and rising incidences of digestive disorders. Moreover, the regulatory environment in North America, particularly in the United States and Canada, supports the use of bacillus coagulans in food and dietary supplements, further driving its market growth.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to large and diverse population, increasing disposable income, and rising health consciousness. Bacillus coagulans, with its ability to withstand high temperatures and acidic environments, is well-suited for fermentation processes, making it a popular choice for enhancing the nutritional value and probiotic content of traditional Asian foods like kimchi, miso, tempeh, and pickles. Furthermore, the prevalence of gastrointestinal disorders and digestive health concerns in the region has heightened awareness of the importance of gut health and probiotics.

Key players in the market

Some of the key players in the Bacillus Coagulans Market include Mitsubishi Chemical Foods Corporation, Aumgene Bioscience, Nebraska Cultures, Syngen Biotech, Sabinsa Corporation, UAS Laboratories, Ganeden, Microbax, Mystical Biotech Pvt. Ltd, Sanzyme, Synbiotics Limited, Lallemand Inc., Bioriginal Food & Science Corp., Unique Biotech Limited and Biovation Labs Inc.

Key Developments:

In February 2024, Bioriginal Food & Science Corp. a wholly-owned subsidiary of Cooke Inc., has announced the acquisition of POS Biosciences Corp. (Saskatoon, Saskatchewan, Canada) from Canopy Growth Corp.

In October 2023, Bioriginal Food & Science Corp. has expanded into Germany with the acquisition of Pflanzenolmuhle Kroppenstedt GmbH operating as Kroppenstedter Olmuhle, a century-old, family-owned mill that specializes in the pressing of plant-based oil products from conventional and organic sources.

In August 2023, Synbiotics Limited acquired CannaCare Health GmbH with its strong CBD brand Canobo as well as the emerging CBD network marketing subsidiary WellnetIQ.

In April 2021, Mitsubishi Chemical Corporation has entered into a partnership agreement with Dymon Co., Ltd. the robot and space development venture, the first private company ever to explore the moon. Based on this agreement, MCC will provide carbon fiber reinforced plastic (CFRP) components and thermoplastic materials as well as technical support.

Product Types Covered:

  • Animal-Based
  • Plant-Based

Forms Covered:

  • Spore
  • Liquid
  • Powder

Distribution Channels Covered:

  • Offline Retail
  • Online Retail

Applications Covered:

  • Cereal
  • Infant Nutrition
  • Non-Dairy
  • Probiotic Supplements
  • Other Applications

End Users Covered:

  • Food & Beverages
  • Cosmetics
  • Nutraceuticals
  • Pharmaceutical
  • Animal Husbandry
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bacillus Coagulans Market, By Product Type

  • 5.1 Introduction
  • 5.2 Animal-Based
  • 5.3 Plant-Based

6 Global Bacillus Coagulans Market, By Form

  • 6.1 Introduction
  • 6.2 Spore
  • 6.3 Liquid
  • 6.4 Powder

7 Global Bacillus Coagulans Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Offline Retail
  • 7.3 Online Retail

8 Global Bacillus Coagulans Market, By Application

  • 8.1 Introduction
  • 8.2 Cereal
  • 8.3 Infant Nutrition
  • 8.4 Non-Dairy
  • 8.5 Probiotic Supplements
  • 8.6 Other Applications

9 Global Bacillus Coagulans Market, By End User

  • 9.1 Introduction
  • 9.2 Food & Beverages
  • 9.3 Cosmetics
  • 9.4 Nutraceuticals
  • 9.5 Pharmaceutical
  • 9.6 Animal Husbandry
  • 9.7 Other End Users

10 Global Bacillus Coagulans Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Mitsubishi Chemical Foods Corporation
  • 12.2 Aumgene Bioscience
  • 12.3 Nebraska Cultures
  • 12.4 Syngen Biotech
  • 12.5 Sabinsa Corporation
  • 12.6 UAS Laboratories
  • 12.7 Ganeden
  • 12.8 Microbax
  • 12.9 Mystical Biotech Pvt. Ltd
  • 12.10 Sanzyme
  • 12.11 Synbiotics Limited
  • 12.12 Lallemand Inc.
  • 12.13 Bioriginal Food & Science Corp.
  • 12.14 Unique Biotech Limited
  • 12.15 Biovation Labs Inc.

List of Tables

  • Table 1 Global Bacillus Coagulans Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 4 Global Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 5 Global Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 6 Global Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 7 Global Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 8 Global Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 9 Global Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 10 Global Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 11 Global Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 12 Global Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 14 Global Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 15 Global Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 16 Global Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 17 Global Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 20 Global Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 21 Global Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 22 Global Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 23 Global Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 24 Global Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 North America Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 28 North America Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 29 North America Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 30 North America Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 31 North America Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 32 North America Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 33 North America Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 34 North America Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 35 North America Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 36 North America Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 37 North America Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 38 North America Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 39 North America Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 40 North America Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 41 North America Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 42 North America Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 43 North America Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 44 North America Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 45 North America Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 46 North America Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 47 North America Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 48 North America Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 Europe Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 52 Europe Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 53 Europe Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 54 Europe Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 55 Europe Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 56 Europe Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 57 Europe Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 58 Europe Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 59 Europe Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 60 Europe Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 61 Europe Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 62 Europe Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 63 Europe Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 64 Europe Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 65 Europe Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 66 Europe Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 67 Europe Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 68 Europe Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 69 Europe Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 70 Europe Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 71 Europe Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 72 Europe Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 75 Asia Pacific Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 76 Asia Pacific Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 77 Asia Pacific Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 78 Asia Pacific Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 79 Asia Pacific Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 80 Asia Pacific Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 81 Asia Pacific Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 82 Asia Pacific Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 83 Asia Pacific Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 84 Asia Pacific Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 85 Asia Pacific Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 86 Asia Pacific Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 87 Asia Pacific Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 88 Asia Pacific Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 89 Asia Pacific Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 90 Asia Pacific Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 91 Asia Pacific Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 92 Asia Pacific Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 93 Asia Pacific Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 94 Asia Pacific Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 95 Asia Pacific Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 96 Asia Pacific Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 99 South America Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 100 South America Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 101 South America Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 102 South America Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 103 South America Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 104 South America Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 105 South America Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 106 South America Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 107 South America Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 108 South America Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 109 South America Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 110 South America Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 111 South America Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 112 South America Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 113 South America Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 114 South America Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 115 South America Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 116 South America Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 117 South America Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 118 South America Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 119 South America Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 120 South America Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 123 Middle East & Africa Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 124 Middle East & Africa Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 125 Middle East & Africa Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 126 Middle East & Africa Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 127 Middle East & Africa Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 128 Middle East & Africa Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 129 Middle East & Africa Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 130 Middle East & Africa Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 131 Middle East & Africa Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 132 Middle East & Africa Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 133 Middle East & Africa Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 134 Middle East & Africa Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 135 Middle East & Africa Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 136 Middle East & Africa Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 137 Middle East & Africa Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 138 Middle East & Africa Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 139 Middle East & Africa Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 140 Middle East & Africa Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 141 Middle East & Africa Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 142 Middle East & Africa Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 143 Middle East & Africa Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 144 Middle East & Africa Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)